ERYTHROMYCIN-RESISTANT STREPTOCOCCUS PNEUMONIAE

Jan Verhaegen(KU Leuven), M.A.T. Coles(Addenbrooke's Hospital), M. Blogie(Centre Hospitalier Universitaire Brugmann), J. Glupczynski(Centre Hospitalier Universitaire Brugmann), L. Verbist(Universitair Ziekenhuis Leuven), E. Yourassowsky(Centre Hospitalier Universitaire Brugmann), D. Haines(Nanotherapeutics (United States)), Enid Walpole(Addenbrooke's Hospital), R E Warren(Addenbrooke's Hospital), Patrick Goubau(Universitair Ziekenhuis Leuven)

The Lancet

December 1, 1988

10.1016/s0140-6736(88)90630-7

Cited by 28

Related Papers

Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study

|The Lancet Infectious Diseases|2011|920

Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

|Clinical Infectious Diseases|2005|593

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation

|Blood|2001|514

Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis

|Journal of Clinical Microbiology|1999|376

Use of Circulating Galactomannan Screening for Early Diagnosis of Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients

|The Journal of Infectious Diseases|2002|342